Your browser doesn't support javascript.
loading
Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
Hughes, Jim H; Phelps, Mitch A; Upton, Richard N; Reuter, Stephanie E; Gao, Yue; Byrd, John C; Grever, Michael R; Hofmeister, Craig C; Marcucci, Guido; Blum, William; Blum, Kristie A; Foster, David J R.
Affiliation
  • Hughes JH; Australian Centre for Pharmacometrics, School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia.
  • Phelps MA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Upton RN; Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Reuter SE; Australian Centre for Pharmacometrics, School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia.
  • Gao Y; School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia.
  • Byrd JC; Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Grever MR; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Hofmeister CC; Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Marcucci G; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Blum W; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Blum KA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
  • Foster DJR; Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Br J Clin Pharmacol ; 85(5): 924-934, 2019 05.
Article in En | MEDLINE | ID: mdl-30672004

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / Leukemia, Lymphocytic, Chronic, B-Cell / Renal Elimination / Lenalidomide / Immunologic Factors Type of study: Prognostic_studies Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: B-Lymphocytes / Leukemia, Lymphocytic, Chronic, B-Cell / Renal Elimination / Lenalidomide / Immunologic Factors Type of study: Prognostic_studies Language: En Year: 2019 Type: Article